KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) EPS (Weighted Average and Diluted) (2016 - 2025)

Evolent Health has reported EPS (Weighted Average and Diluted) over the past 12 years, most recently at -$3.84 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$3.84 for Q4 2025, down 1322.22% from a year ago — trailing twelve months through Dec 2025 was -$5.15 (down 528.05% YoY), and the annual figure for FY2025 was -$5.07, down 525.93%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$3.84 at Evolent Health, down from -$0.24 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for EVH hit a ceiling of $0.03 in Q4 2021 and a floor of -$3.84 in Q4 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.23 (2024), compared with a mean of -$0.39.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 123.08% in 2021 and later crashed 1600.0% in 2023.
  • Evolent Health's EPS (Weighted Average and Diluted) stood at $0.03 in 2021, then plummeted by 466.67% to -$0.11 in 2022, then plummeted by 227.27% to -$0.36 in 2023, then rose by 25.0% to -$0.27 in 2024, then crashed by 1322.22% to -$3.84 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$3.84 (Q4 2025), -$0.24 (Q3 2025), and -$0.44 (Q2 2025) per Business Quant data.